Clinical Trial Update: A Study of Once Monthly Intravenous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia. [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating once-monthly intravenous Mircera for maintenance treatment of anemia in dialysis patients with chronic renal anemia; results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 4 | Status: COMPLETED | Results posted: 2016-04-29